Skip to main content
Smart Investors Daily
US

NYSE · USPH

U.S. Physical Therapy, Inc.

Healthcare · Medical - Care Facilities

$94.32

Up+$1.61 (+1.71%)

Updated Nov 20, 2026, 11:05 PM

SID Score

6.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.22B
P/E ratio
36.55
Dividend yield
1.91%
52-week range
$58.19 – $101.80
Volume
301.24K
Avg. volume
170.58K

Price performance · USPH

USPH price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

USPH closed at $94.32 after 21 trading sessions, up 6.30% for the selected period.

Last close
$94.32
Period change
+6.30%
Period low
$84.74
Period high
$100.10
Daily close
View OHLC price history
USPH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$94.44$95.80$93.20$94.32301.24K
Nov 18, 2026$96.64$98.42$95.01$95.43330.68K
Nov 17, 2026$98.45$100.66$97.28$97.34300.49K
Nov 16, 2026$100.23$100.61$99.10$99.55220.16K
Nov 13, 2026$99.09$100.655$96.39$99.60148.43K
Nov 12, 2026$100.74$101.80$97.71$98.60139.79K
Nov 11, 2026$99.10$100.4775$98.70$100.10166.13K
Nov 10, 2026$99.88$100.00$96.86$99.24177.43K
Nov 9, 2026$99.91$100.4529$98.40$99.84324.94K
Nov 6, 2026$96.62$101.1786$96.22$99.49295.07K
Nov 5, 2026$94.00$100.98$94.00$97.20309.31K
Nov 4, 2026$86.72$89.91$86.69$89.18283.26K
Nov 3, 2026$84.95$86.60$84.62$84.74191.15K
Nov 2, 2026$86.40$86.62$84.26$84.90334.71K
Oct 30, 2026$87.26$87.62$85.19$85.83146.43K
Oct 29, 2026$86.45$86.92$85.73$86.57105.18K
Oct 28, 2026$86.35$88.35$85.13$85.32187.3K
Oct 27, 2026$88.45$88.93$86.58$87.34187.95K
Oct 26, 2026$88.98$89.98$88.575$88.6576.19K
Oct 23, 2026$88.16$88.86$85.44$88.53102.91K
Oct 22, 2026$86.71$88.87$86.30$88.73129.98K

Latest USPH news

The latest Smart Investors Daily articles mentioning USPH.

USPH research

Overview

Company profile and research snapshot.

Company profile

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$98.00
Implied upside
—
Analysts
13
USPH recent ratings
DateFirmRatingTarget
Nov 13, 2026Barrington ResearchOutperform—
Nov 6, 2026Barrington ResearchOutperform—
Sep 11, 2026JP MorganOverweight—
Aug 10, 2026Barrington ResearchOutperform—
Jun 24, 2026CitizensMarket Outperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 9, 2026

The 5 most interesting analyst questions from U.S. Physical Therapy’s Q3 2026 earnings call

U.S. Physical Therapy delivered a quarter that surpassed Wall Street’s expectations, with management attributing the outperformance to strong execution of its hospital partnership strategy and sustained volume growth. CEO Chris Reading credited the company’s ability to maintain record patient visits per clinic, even through a seasonally softer period, as a key factor. The integration of Metro N.Y. and Gulf Coast hospital affiliations led to a significant increase in hospital-based revenue, which

Yahoo · Nov 7, 2026

U.S. Physical Therapy Q3 Earnings Call Highlights

U.S. Physical Therapy (NYSE:USPH) reported double-digit revenue and EBITDA growth for the third quarter of 2026 as higher patient volumes and reimbursement rates from hospital affiliations helped offset rising employee health costs. The company reaffirmed its full-year EBITDA guidance of $102 milli

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.